Keto Diet Outperforms Other Diets in New Metabolic Health Trial

The trial was a randomized study involving 55 adults with metabolically unhealthy obesity, who were assigned to one of three diets (ketogenic, Mediterranean, or plant-forward low-fat) for five months with strict adherence and provided meals to ensure protocol fidelity.
Among the three diets, the ketogenic arm achieved a 67% reduction in liver fat, a magnitude of improvement not matched by the other diet groups in the study.
Beyond liver fat, the ketogenic diet showed greater changes in hormones and insulin levels linked to liver-fat metabolism than the Mediterranean or low-fat diets, indicating metabolic benefits beyond weight loss.
The study is small and short-term, raising questions about the durability of the benefits and the need for longer-term research to assess sustainability and long-term health outcomes.
A new clinical trial from Washington University School of Medicine found that the ketogenic diet outperforms Mediterranean and low-fat diets for people with obesity and metabolic health problems News Medical. Over five months, people on keto saw a 67% reduction in liver fat—far more than the other two groups. The diet also improved blood sugar control and insulin levels more effectively, suggesting real metabolic benefits beyond simple weight loss Head Topics.
Researchers assigned 55 adults with obesity to one of three diets for five months KPVI. All participants received prepared meals to ensure they stuck to their assigned plan—no cheating allowed. The three groups were: ketogenic (very low carbs, high fat), Mediterranean (balanced with lots of vegetables and olive oil), and plant-forward low-fat. Strict adherence was critical to see which diet's composition actually mattered most Post Guam.
The ketogenic group achieved a stunning 67% drop in liver fat deposits News Medical. This improvement far exceeded what the Mediterranean and low-fat groups saw. Keto also produced bigger changes in hormones and insulin markers tied to liver-fat metabolism. These shifts point to real metabolic healing—not just the scale moving down Head Topics. For people with fatty liver disease or prediabetes, the difference was especially pronounced.
Importantly, the Mediterranean and low-fat diets did improve metabolic health overall KPVI. No diet was a failure. But when researchers compared the three side by side, the ketogenic approach delivered extra benefits for liver fat and blood-sugar markers. This suggests that diet composition—not just eating less—matters for metabolic risk factors like prediabetes and fatty liver Erie News Now.
The trial lasted only five months and included just 55 people Post Guam. While those results look promising, scientists caution that longer research is needed to confirm the benefits hold up over years, not weeks. They also want to know whether people can stick with keto long-term and whether the metabolic improvements last once the trial ends. For now, keto shows real promise for metabolic health in obese adults with prediabetes or fatty liver.
Publishers
10
Articles
139
Reach
149